India Glioblastoma Market Size, Share, and Forecast Analysis to 2035
According to the latest India Glioblastoma Industry Insights, treatment paradigms in India are rapidly shifting from conventional chemotherapy toward combination protocols and novel targeted therapies. While surgical resection followed by radiotherapy and temozolomide remains the first-line gold standard, emerging therapeutic modalities are capturing market attention.
Primary Treatment Segments
-
Surgery: Fluorescence-guided surgical resections (e.g., using 5-ALA) improving extent of resection.
-
Radiation Therapy: Rapid adoption of Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Radiosurgery (SRS/Gamma Knife).
-
Targeted Therapy & Immunotherapy: Increasing clinical evaluation of anti-angiogenic agents (e.g., bevacizumab) and targeted kinase inhibitors.
-
Tumor-Treating Fields (TTFields): Emerging non-invasive therapy options disrupting cancer cell division.
Explore key developments shaping industry transformation:
Protein Microarray Market Trends
Long QT Syndrome Market Growth